Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA-824 Dose Ranging EBA Trial in Pulmonary TB
NCT00944021Phase 2Completed
- Sponsor
- TB Alliance
- Start
- Aug 2009
- Primary completion
- Jan 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of pretomanid in pulmonary tuberculosis (TB) (5 arms), sponsored by TB Alliance. Primary endpoint: Early Bactericidal Activity (Days 0-14) at 14 days. Started Aug 2009; status: completed.
02
Drugs
pretomanid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00944021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944021.